Background Bone marrow derived mesenchymal stem cells (BM-MSCs) are used extensively in transplantation but their use is associated with many problems including low abundance in BM, low overall number, decreased differentiation potential with age and the invasive isolation procedures needed to obtain BM. We report a novel method of isolating placental MSCs (pMSCs) from chorionic villi, which exhibit the phenotypic and functional characteristics that will make them an attractive source of MSCs for cell-based therapy. Methods A novel explant approach was used to isolate pMSCs from chorionic villi of human placentae. These pMSCs were characterized by flow cytometry and were differentiated into adipocytes, osteocytes and chondrocytes using differentiation medium as demonstrated by cytochemical staining. The gene and protein expression profiles of pMSCs were also characterized using real time polymerase chain reaction (PCR) and flow cytometry, respectively. In addition, cytokine secretion by pMSCs was also analysed using sandwich enzyme-linked immunosorbent assay (ELISA) technique. Moreover, the migration and proliferation potentials of pMSCs were also determined. Results pMSCs were isolated from fetal part of the chorionic villi and these pMSCs expressed CD44, CD90, CD105, CD146, CD166 and HLA-ABC but not CD14, CD19, CD40, CD45, CD80, CD83, CD86 and HLA-DR. In addition, these pMSCs differentiated into osteocytes, chondrocytes and adipocytes and they also expressed several adhesion molecules, chemokines/receptors, growth factor receptors and cytokines/receptors. Moreover, they secreted many cytokines (IL-1Ra, IL6, IL8, IL10, IL11 and IL15) and they were able to proliferate. Furthermore, they migrated in response to chemotactic factors including stromal cellderived factor-1 (SDF-1), platelet derived growth factor (PDGF), hepatocyte growth factor (HGF), and monocyte chemotactic protein-1 (MCP-1). Conclusions We devised a novel explant method of isolating pMSCs that expressed many biological factors responsible for mediating cellular processes such as migration/ homing, immune modulation and angiogenesis. Therefore, we suggest that pMSCs prepared from human term placental chorionic villous explants are an attractive source of MSCs for cell therapy.
Introduction
Stem cells are broadly classified as embryonic stem cells (ESCs) or adult stem cells (ASCs). ESCs can be obtained from the blastocyst of the early embryo. ESCs are pluripotent and differentiate into cell derivatives of the three germ layers: endoderm, ectoderm and mesoderm. Adult stem cells can be derived from a variety of tissues. However, the most characterized source of ASCs is the adult bone marrow (BM). One main subset of ASCs is the mesenchymal stem cells (MSCs). MSCs were firstly described as spindle shaped cells derived from BM that adhered to plastic and formed fibroblast colonies, which were called colonyforming unit fibroblasts (CFU-F) [1] . MSCs are multipotent cells can differentiate into cell derivatives of the mesenchymal lineage, including adipocytes, osteocytes, chondrocytes and myocytes [2, 3] . In addition, there is some evidence that MSCs can "transdifferentiate" into hepatocytes, neurons and astrocytes [4] . MSCs have been isolated from a variety of adult tissues including liver, bone marrow, dental pulp, adipose-tissue, endometrium, muscle, amniotic fluid, placenta and umbilical cord blood [5] [6] [7] [8] [9] [10] [11] .
There is much discussion in the literature about the real nature of cells called MSCs since heterogeneous populations of cells isolated using a range of procedures have been called MSCs. Currently, the International Society for Cellular Therapy has provided minimum criteria to identify MSCs; MSCs must be plasticadherent, more than 95 % of the population must express CD105, CD73 and CD90, and lack the expression of CD45, CD34, CD14 or CD11b, CD79a or CD19 and HLA class II. MSCs must differentiate to osteocytes, adipocytes and chondrocytes in vitro [12] .
Regardless of the absence of decisive markers for MSCs, the heterogeneous nature of MSC populations and variations in their differentiation potential, MSCs remain an attractive source of stem cells for the treatment of human diseases [13, 14] .
Clinically, human adult BM is the usually used as a source of MSCs. However, the use of adult BM has limitations. First, the abundance of MSCs in adult BM is low (approximately 0.001-0.01 %) [15] . In addition, the overall number and differentiation potential of BMMSCs decreases with age [16] . Moreover, BM harvesting is an invasive procedure. Consequently, the search for alternative sources of MSCs that could be used clinically is essential. Placenta is abundantly available and easily accessible because it is discarded after normal delivery. The placenta has become increasingly attractive as a source of MSCs. Several researchers isolated pMSCs and characterized their growth kinetics, cell marker expression, and multilineage differentiation into osteocytes, chondrocytes, adipocytes, and neuronlike cells [8, [17] [18] [19] . However, in contrast to BMMSCs, the biological characteristics of pMSCs are poorly understood. For stem cell-based therapy, it is essential to isolate highly enriched populations of MSCs and to identify the spectrum of molecules they express, which mediate important cellular functions including homing/migration, proliferation, differentiation, immune modulation and angiogenesis.
In this study, we developed a novel method to isolate highly enriched MSCs, with increased yields, from the chorionic villi of human placentae by treating tissues with Trypsin. MSCs were characterized for their expression of a broad spectrum of adhesion molecules, chemokines/receptors, cytokines/receptors and growth factors. Also, we examined the ability of these pMSCs to secrete cytokines, to proliferate and also to migrate in vitro. Our study demonstrated the potential of pMSCs from chorionic villous explants as a source of MSCs for cell based therapy.
Materials and Methods

Ethics of Experimentation
This study was approved by the institutional research board at King Abdulla International Medical Research Centre/ King Abdulaziz Medical City, Riyadh, Saudi Arabia. All placentae were obtained with informed consent.
Placentae
Human placentae were obtained from uncomplicated pregnancies following normal vaginal delivery (38-40 weeks of gestation). The gestational age and fetal viability of all pregnancies were confirmed by early ultrasound examination before 20 weeks gestation. The placentae were used within 2 h of delivery.
Isolation of Mesenchymal Stem Cells from Placental Explants In Vitro
To isolate pMSCs from chorionic villi, the explant approach was used. Tissues from 20 placentae were dissected and washed with ice-cold phosphate buffered saline (PBS), pH 7.4. After separating and discarding the maternal decidua that remains attached to the surface of the cotyledons, the chorionic villi from the fetal portion were cut into pieces of approximately 40 mg wet weight and washed with PBS and then incubated with 2.5 % trypsin (Invitrogen, Saudi Arabia) diluted in Dulbecco's Modified Eagle Medium Nutrient Mixture F-12 (DMEM-F12) (Invitrogen, Saudi Arabia) containing (271 unit/ml) DNase (Invitrogen, Saudi Arabia), 100 μg/ml streptomycin and 100 U/l penicillin with gentle rotation at 4°C overnight. Trypsin untreated tissues were cultured immediately as described below. Following washing of untreated or trypsin-treated tissues with PBS for three times, the tissues were allowed to adhere to the plastic in 6 well plates (BD, Saudi Arabia) at 37°C in a humidified atmosphere containing 5 % CO 2 and 95 % air for 60 min. Then, DMEM-F12 medium containing 10 % Mesenchymal Stem Cell Certified fetal bovine serum (MSCFBS) (Invitrogen, Saudi Arabia), 100 μg/ml of L-glutamate, 100 μg/ml streptomycin and 100 U/l penicillin was gently added to the tissues and cultured at 37°C in a humidified atmosphere containing 5 % CO 2 and 95 % air. Every two days, the medium was removed and replaced with fresh medium. On day 14, the tissues were removed and cells migrated out from the cut ends of the tissues were then harvested with TrypLE™ Express detachment solution (Invitrogen, Saudi Arabia) and counted using Trypan blue on a haemocytometer chamber. The number of cells was expressed as the total number of cells per cultured 40 mg of tissue. Cells at a density of 1×10 5 cells in 75 cm² flask (Becton Dickinson, Saudi Arabia) were re-cultured until they reached 75 % confluency and then were used in subsequent experiments. Cells were visualized under an inverted Nikon ECLIPSE Ti U microscope (Nikon, Saudi Arabia) and photomicrographs were recorded using Nikon DS-Qi1 camera and Software (Nikon, Saudi Arabia). Twenty placentae were used in this study. Cells were isolated from passage zero to passage five. Untreated and Trypsin-treated tissues were analyzed in subsequent experiments. Passage zero is defined as the cells which were harvested immediately after the removal of tissues.
Flow Cytometry
Cells were harvested using TrypLE™ Express detachment solution. For analysis, 1×10
5 of cells were stained with antibodies listed in Table 1 for 30 min and then were washed twice with cold PBS by centrifugation at 150×g for 5 min at 8°C. The expression of the corresponding cell surface proteins was assayed by an FC500 (Beckman Coulter, Saudi Arabia) flow cytometer.
Colony Forming Unit (CFU) Assay
Colony forming efficiency of pMSCs was assessed using CFU assay in which cells were seeded into six well plates at a density of 100 cells/well in DMEM-F12 medium containing 10 % MSCFBS, 100 μg/ml of L-glutamate, 100 μg/ml streptomycin and 100 U/l penicillin. The medium was replaced with fresh medium every 3 days. After 14 days incubation at 37°C in a humidified atmosphere containing 5 % CO 2 and 95 % air, the medium was removed and the cells were then washed with PBS for three times. Cells were then fixed with 4 % paraformaldehyde in PBS, pH 7.4 for 30 min at room temperature (RT). After washing cells twice with PBS, they were stained with haematoxylin (Invitrogen, Saudi Arabia) for 5 min at RT, rinsed with distilled water, visualized under Micros ASTRIA MCX100LCD light microscope (MICROS, Saudi Arabia), and images were then captured for analysis. Aggregates of ≥50 cells were scored as colonies. Each experiment was performed on twenty separate occasions and samples were in triplicate unless otherwise specified. The numbers of passages and placentae were as above.
Osteogenic Induction
Cells at a density of 7.4×10 3 were seeded in 8-well culture slide (Becton Dickinson, Saudi Arabia) in DMEM-F12 Chondrogenic Induction Cells at density of 2.5×10 5 in a 15 ml conical tube were centrifuged at 200×g for 5 min at RT. After removing the culture medium, cells were resuspended in DMEM-F12 medium and centrifuged at 200×g for 5 min at RT. After aspirating the medium, cells were resuspended in chondrogenic differentiation medium containing chondrogenic supplement (Part # 390417, R & D systems, Saudi Arabia), 10 % MSCFBS, 100 μg/ml of L-glutamate, 100 μg/ml streptomycin and 100 U/l penicillin and then centrifuged at 200×g for 5 min at RT. After centrifugation, the medium was not removed from the tube in order not to disturb the cell pellet. The cap was then loosened to allow gas exchange and the tube was incubated at 37°C in a humidified atmosphere containing 5 % CO 2 and 95 % air. The medium was replaced with fresh medium every three days without disturbing the cell pellet. After 21 days, the chondrocyte pellet was gently washed twice with PBS and liquid nitrogen was then used to freeze cell pellet in cryo-embedding medium (Leica Microsystems, Saudi Arabia). The frozen cell blocks were cut into 10 μm serial sections using a cryostat (Thermo Scientific, Saudi Arabia) and collected on glass slides (Leica Microsystems, Saudi Arabia). Slides were then fixed in 4 % (w/v) paraformaldehyde in PBS, pH 7.4 for 20 min at RT. After washing slides twice with PBS, they were stained with 1 % Alcian Blue solution prepared in 0.1 N HCL for 30 min at RT. After rinsing slides with 0.1 N HCl for three times, distilled water was added to neutralize the acidity. Then, the slides were visualized under the light microscope and images were captured. The number of replicates, passages, numbers of placentae and controls were as above.
Adipogenic Induction
Cells at a density of 3.7×10 4 were seeded in 8-well culture slide in DMEM-F12 culture medium containing 10 % MSCFBS, 100 μg/ml of L-glutamate, 100 μg/ml streptomycin and 100 U/l penicillin and then incubated at 37°C in a humidified atmosphere containing 5 % CO 2 and 95 % air. When cells were 100 % confluent, the medium was removed and cells were then washed twice with PBS and cultured in adipogenic differentiation medium containing adipogenic supplement (Part # 390415, R & D systems, Saudi Arabia), 10 % MSCFBS, 100 μg/ml of L-glutamate, 100 μg/ml streptomycin and 100 U/l penicillin. Then, cells were incubated at 37°C in a humidified atmosphere containing 5 % CO 2 and 95 % air. The medium was replaced with fresh Medium every three days. After 21 days, adipocytes were washed twice with PBS and fixed with 4 % paraformaldehyde in PBS, pH 7.4 for 20 min at RT. After washing cells twice with PBS, they were incubated with 100 fold dilution LipidTOX™ Green Neutral Lipid Stain for 30 min in the dark at RT and then were rinsed twice with PBS. Finally, SlowFade® Gold (Invitrogen, Saudi Arabia) was applied and cells were visualized under Nikon ECLIPSE 80i fluorescent microscope and images were captured using Nikon DS-Qi1 camera and Software. The number of replicates, passages, numbers of placentae and controls were as above.
Gene Expression Profile of Human Placental Mesenchymal Stem Cells (pMSCs)
To determine the expression of genes listed in Table 2 , real time polymerase chain reaction (RT-PCR) was performed in which QuantiTect Primer Assay (Qiagen, Saudi Arabia) was used according to the manufacturer's instructions. Following extraction of total RNA from cells using the FastLane Cell cDNA kit (Qiagen, Saudi Arabia) according to the manufacturer's instructions, cDNA was synthesised using the Fast Lane Cell cDNA kit and RT Primer Mix (Qiagen, Saudi Arabia) at 42°C for 30 min. Then, mRNA was quantified by real-time PCR using QuantiTect SYBR Green PCR Kit (Qiagen, Saudi Arabia), according to the manufacturer's instructions and the reaction was then carried out in triplicate on the CFX96 real-time PCR detection system (BIO-RAD, Saudi Arabia). The data were then analysed using CFX manager software (BIO-RAD, Saudi Arabia). The assessment of gene expression was based on the following CT (cycle threshold) values: negative expression (-) if CT value is zero, weak expression (+) if CT>35, moderate expression (++) if CT between 29 and 35 and strong expression (+++) if CT<29.
The relative expression level of the housekeeping gene β-actin or GAPDH or 18S rRNA was used to normalize target gene expression. Also, relative quantitation of target genes was expressed as a percentage of the housekeeping gene product as previously described [20] . Cells isolated from passage one of twenty placentae were analyzed in this study.
Enzyme-Linked Immunosorbent Assay (ELISA) for Detection of Cytokines Secretion of IL1Ra, IL4, IL6, IL8, IL10, IL11, IL13, IL16, IL4 and IL20 was assayed by the Quantikine Human Immunoassay kits (R & D Systems), according to the manufacturer's instructions. Cells were washed three times with PBS and then cultured for 48 h at a density of 2×10 6 in 6 well plate containing DMEM-F12 medium composed of 10 % MSCFBS, 100 μg/ml of L-glutamate, 100 μg/ml streptomycin and 100 U/l penicillin at 37°C in a humidified atmosphere containing 5 % CO 2 and 95 % air. Conditioned media derived from the cultured cells were analysed by the quantitative sandwich immunoassay. Culture medium not incubated with cells was used as the negative control. Each experiment was performed in duplicate. Cells isolated from passage one of 10 placentae were analyzed.
Proliferation of pMSCs
The effect of selected cytokines on the proliferation of pMSCs was studied by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay using Vybrant® MTT Cell Proliferation Assay Kit (Invitrogen, Saudi Arabia). In brief, cells were seeded at a density of 2×10 3 per well in 96-well tissue culture plates containing DMEM-F12 medium with 10 % MSCFBS, 100 μg/ml of L-glutamate, 100 μg/ml streptomycin and 100 U/l penicillin and then cultured at 37°C in a humidified atmosphere containing 5 % CO 2 and 95 % air. We examined nine human recombinant cytokines (3 ng/ml IL-4, 400 ng/ml hepatocyte growth factor (HGF), 10 ng/ml IL-1, 10 ng/ml IL-6, 150 ng/ml IL8, 40 ng/ml Rantes and 40 ng/ml IL7A) [21] . These cytokines were dissolved in culture medium and then added to the cell culture and incubated at 37°C in a humidified atmosphere containing 5 % CO 2 and 95 % air for 48 h. The used concentrations gave an optimal effect as shown in our dose response experiment and also as previously shown [21] . After replacing the medium with fresh medium, cells were treated with 0.5 mg/ml MTT solution and then were incubated at 37°C for 4 h. Then, the dark blue formazan product of MTT was lysed with 40 mM HCl in isopropyl alcohol and measured at 570 nm using an ELISA plate reader (Spectra MR, Dynex Technologies, Saudi Arabia). 0.5 mg/ml MTT solution in medium not exposed to cells was used as the negative control. The number of replicates, cell passage and number of placentae were as above. 
Migration of pMSCs
Migration assays were performed in transwell inserts (BD, Saudi Arabia) with 8 μm pore filters in 12 well plates. Cells at a density of 5×10 5 were added to the upper side of the transwell filter chamber in a 12 well plate and DMEM-F12 migration medium containing 100 μg/ml of L-glutamate, 100 μg/ml streptomycin and 100 U/l penicillin with chemotactic factors was added to the bottom chamber. Migration observed in the presence of 30 % FBS and with medium alone served as positive and negative controls, respectively. After overnight incubation at 37°C in a humidified atmosphere containing 5 % CO 2 and 95 % air, the upper side of the filters was carefully washed with PBS and cells remaining on the upper face of the filters were gently removed with a cotton wool swab. Transwell filters were stained using haematoxylin for 1 min, and then washed with tap water, cut out with a scalpel, and mounted with Aquamount onto glass slides, putting the lower face on the top and then covered with coverslips. The total number of cells that had migrated was counted using light microscopy at 100× magnification. To avoid a bias related to microscopic counting, cells were blind counted. Data were expressed as numbers of total migrated cells per insert related to that of the negative control. We examined the chemotactic activity of stromal derived factor, SDF (150 ng/ml), platelet derived growth factor, PDGF (10 ng/ml), hepatocyte growth factor, HGF (50 ng/ml), and MCP (100 ng/ml). All chemotactic factors used were recombinant factors of human origin (R & D Systems, Saudi Arabia). The used concentrations gave an optimal migratory effect as previously published [22] . The number of replicates, cell passage and number of placentae were as above.
Statistical Analysis
Data were analysed using the t-test. These analyses were performed using GraphPad Prism 5. Results were considered to be statistically significant if P<0.05.
Results
Isolation, Flow Cytometry Analysis and Differentiation of pMSCs
Chorionic villi (approximately 40 mg wet weight) were treated with 2.5 % Trypsin and then were attached to the plastic surface in 6 well plates and cultured in DMEMF-12 medium containing 10 % MSCFBS for 14 days. The pMSCs migrated out of untreated and trypsin treated tissues exhibited a fibroblast like cell morphology (Fig. 1) . Contamination of maternal derived cells in the pMSC populations was assessed by detecting SRY gene using real time PCR. The real time PCR of all samples (pMSCs isolated from passage zero to passage five of untreated and trypsin-treated tissues of 20 placentae) resulted in amplification products with SRY primers, which were detected at a CT value of 23 (±2) of 40 cycles. The GAPDH housekeeping gene was detected at CT value of 15 (±3) of 40 cycles in all samples. Medical records revealed all placental stem cell preparations that gave SRY signals corresponded to pregnancies with male births, whereas those preparations that did not amplify with SRY primers were from female births. This confirms that pMSC preparations contained fetal-derived cells. The number of cells migrated out from the cut ends of the tissues after 14 days in culture was counted using Trypan blue on a haemocytometer chamber. The total number of migrated cells was then expressed per 40 mg of cultured tissue. The result showed that Trypsin significantly increased (P<0.0001) the number of cells produced by the explanted chronic villi as compared to Trypsin untreated villi (Fig. 1 (Fig. 1) .
We determined the phenotype of MSCs isolated from both untreated and Trypsin-treated tissues by flow cytometry. Cells at passage zero of Trypsin-treated tissues were positive for MSC markers including CD44 (97 %±3 %), CD90 (94 %±6 %), CD146 (93 %±7 %), CD166 (98 %± 2 %) and CD105 (99 %±1 %). The expression of MSC markers by pMSCs increased at passage one ( Fig. 2) but then did not change significantly through serial passages (passage two to passage five) (data not shown). Also, these cells isolated from passage zero to passage five expressed HLA-ABC (99 %±1 %). In addition, they were negative for CD19, CD45, HLA-DR, CD80, CD86, and CD40 (Fig. 2) . Similarly, cells isolated from untreated tissues were positive for all MSC markers and HLA-ABC and they were also negative for CD19, CD45, HLA-DR, CD80, CD86, and CD40 (data not shown). This expression of molecules by cells isolated from untreated tissues did not decrease/change through serial passages (data not shown). In addition, the expression profile of these markers by cells isolated from untreated and Trypsin-treated tissues were not significantly different (data not shown).
To estimate the potential of pMSC differentiation into several cell lineages, pMSCs isolated from Trypsin-treated chorionic villi were only studied since the phenotype markers expressed by pMSCs and the chondrogenic efficiency (below) of pMSCs isolated from untreated and Trypsin-treated tissues were not significantly different or changed through serial passages (data not shown). Therefore, cells isolated from Trypsin-treated chorionic villi were cultured in adipogenic, osteogenic and chondrogenic medium. At the end of the induction period, cells were differentiated into their respective cells. The qualitative confirmation of differentiation was made by Alizarin Red S solution for osteogenic differentiation, Alcian Blue solution for chondrogenic differentiation and LipidTOX™ Green Neutral Lipid Stain for adipogenic differentiation (Fig. 3) . In addition, the qualitative differentiation potential of pMSCs through serial passages (zero to five) was the same for the 10 placentae studied.
Colony Forming Unit Assay
Cells were clonogenic as shown by colony forming unit assay (Fig. 3) . Clusters of ≥50 cells were counted as colonies. Seeding cells at density of 100 cells per well resulted in 19.1±2.2 % and 21.5±3.7 of the total cells isolated from untreated and trypsin treated tissues, respectively per well forming colonies, with an average of 51.1±7.2 cells/colony and 53.6±10.3 cells/ colony for cells isolated from untreated and Trypsin-treated tissues, respectively (26 colonies counted for each sample). The clonogenic ability of MSCs isolated from untreated and Trypsin-treated tissues did not differ significantly or change through serial passages (data not shown).
Characterization of pMSCs by Real Time PCR and Flow Cytometry Techniques
The pMSCs from passage one of Trypsin-treated tissues were examined for the expression of genes encoding adhesion molecules, chemokines/receptors, cytokines/receptors and growth factors using PCR. The level of mRNA expression was assessed based on the CT value. We analysed 47 cytokines, 55 chemokines, 35 adhesion molecules, 30 growth factors (Table 2 ). In addition, the expression of some of these proteins by pMSCs was also examined using flow cytometry (Table 1) . pMSCs expressed a broad spectrum of adhesion molecules, chemokines/receptors, cytokines/ receptors and growth factors as shown in Tables 3, 4 , 5 and 6.
Human pMSCs Express a Distinct Set of Adhesion Molecules
Human pMSCs expressed a broad spectrum of adhesion molecules including integrin (α1, α2, α2b, α3, α4, α5, α6, α7, α8, α10, α11, αE, α M, αV, β1, β3, β4, β5, β6, β7, β8), selectin P ligand and immunoglobulin superfamily (ICAM1, ICAM2, PECAM, VCAM and neuroplastin) as shown in Table 3 . In addition, the flow cytometry analysis of surface protein expression by pMSCs revealed that pMSCs expressed ICAM-1 (CD54) (74.6±13 %). /receptors including inflammatory IL1A, IL1B,   IL6, IL8, IL12A, IL15, IL16, IL18, IL20, IL23A,  IL26, IL27, IL28A, IL29, IL31, IL32, IL33, IL34,  IL1R1, IL6R, IL7R, IL17RC and tumor necrosis factor  receptor superfamily, member 1A and 1B and antiinflammatory cytokines/receptors IL4, IL5, IL6, IL10,  IL19, IL24, IL25, IL27, IL32, IL4, IL6 and IL10RA  as shown in Table 5 . In addition, the FACS analysis of surface protein expression by pMSCs revealed that pMSCs expressed CD130 (31.4 %±17 %), the signal- transducing receptor for cytokines of the IL-6 family but lacked the expression of tumor necrosis factor receptor superfamily, member 1A (CD120a) and 1B (CD120b) and interleukin-7 receptor-α (CD127) as well as IL8.
Human pMSCs Express a Distinct Set of Growth Factor Receptors
Human pMSCs expressed a broad spectrum of growth factor receptors including platelet-derived growth factor receptor, interferon gamma receptor 1 and 2, interferon (alpha, beta and omega) receptor 1 and 2, fibroblast growth factor receptor 1 and 3, transforming growth factor, beta receptor 1 and II, epidermal growth factor receptor, insulin-like growth factor 1 receptor, colony stimulating factor 2 receptor, beta, formyl peptide receptor 2, opioid growth factor receptor, vascular endothelial growth factor, vascular endothelial growth factor receptor 2, hepatocyte growth factor receptor, epidermal growth factor as shown in Table 6 .
Human pMSCs Express Immune Suppressive Genes and Negative Co-signalling Proteins
The analysis of mRNA expression of pMSCs isolated from passage one of Trypsin-treated tissues revealed that these cells expressed the immunosuppressive en- Table 4 The expression of chemokine receptors and chemokine ligands in human placental mesenchymal stem cells (pMSCs) as determined by real time PCR: (−) no expression: (+) weak expression: (++) moderate expression: (+++) strong expression of mRNA 
Chemokines Results Chemokines Results Chemokines Results Chemokines Receptors Results Chemokines Receptors Results
zyme indoleamine-2,3-dioxygenase (IDO). In addition, the flow cytometry analysis showed that pMSCs expressed the negative co-signalling proteins B7H-3 (99.4 %± 1 %), CD273 (55.5 % ± 10 %) and CD274 (53.3 %±15 %). In contrast, pMSCs lacked the expression of the positive co-signalling protein, B7H2 and the program death receptor (CD279).
Human pMSCs Secrete Various Cytokines
Stem cells are known to regulate the functions of many cells through the secretion of cytokines. Therefore, we explored whether the pMSCs isolated from passage one of Trypsintreated tissues secreted cytokines or not. Several cytokines was detected in the conditioned medium of pMSCs by ELISA. This includes IL1Ra (915 pg/ml ± 77), IL6 (294 pg/ml±54), IL-8 (254 pg/ml±43), IL-10 (244 pg/ml± 34), IL-11 (451 pg/ml±62) and IL-15 (176 pg/ml±92).
The Proliferation Potential of pMSCs
In attempt to determine whether pMSCs isolated from passage one of Trypsin-treated tissues can proliferate in response to cytokines, we studied the effect of different cytokines on the proliferation of these pMSCs using the MTT assay. The results showed that IL-4 and HGF significantly inhibited (P<0.01) the proliferation of pMSCs as shown in Fig 
Discussion
A Novel In Vitro Model to Isolate pMSCs from Chorionic Villous Explants
In this study, we developed a novel method to isolate MSCs from fetal portion of the chorionic villi of human placentae. We have modified the previously published explant approach which was shown to be a better choice than the enzyme digestion methods since it can isolate MSCs from the chorionic villi without generation of extracellular matrix, damaged cells, endothelial cells and blood cells [23, 24] . We treated chorionic villi with Trypsin, which increased the (Fig. 1) . The mechanism by which Trypsin mediates this effect needs to be further investigated, but it is possible that this digestive enzyme [25] disrupted the structure of the placenta that facilitated the movement of MSCs out of their niche [26] . In addition, Trypsin did not change the morphology of pMSCs. pMSCs isolated from both untreated and Trypsin-treated tissues exhibited a fibroblast like cell morphology (Fig. 1) . We cultured pMSCs, which were isolated from untreated and Trypsin-treated tissues, for five passages. Interestingly, the hematopoietic cells in pMSC populations were absent from passage zero to passage five (Fig. 2) . This result is novel since previous studies have reported that the frequency of hematopoietic cells diminished after serial passages in culture [23, 24, 27] . In addition, pMSCs isolated from passage zero of Trypsin treated-tissues were positive for MSC markers, HLA-ABC, and were negative for HLA-DR and the co-stimulatory molecules (Fig. 2) . The expression of these molecules by pMSCs isolated from untreated and Trypsin treated-tissues was similar and also did not decrease through serial passages in culture. In addition, these pMSCs exhibited differentiation and clonogenic abilities (Fig. 3) ; thus further confirmation that these cells have stem cell-like properties.
We are the first to perform this extensive phenotypic, differentiation and self-renewal analysis on pMSCs isolated from serial culture passages. Our method can yield highly enriched pMSC populations in a time period (~two weeks) less than the previously published time [23, 24] . In addition, Trypsin treatment can increase the number of pMSCs produced by the explants without affecting the phenotype or differentiation or self-renewal abilities of pMSC. Consequently, our method can be a better choice in the field of stem cell research to isolate and enrich pMSC populations in early passages.
pMSCs Express a Specific Combination of Adhesion Molecules
Adhesion molecules play major roles in several cellular processes, such as cell growth, differentiation and homing. Adhesion molecules are classified into immunoglobulin superfamily cell adhesion molecules (CAMs), integrins, cadherins, and selectins. Our study is the first to show the expression of a comprehensive range of adhesion molecules by pMSCs (Table 3 ). In addition, we showed for the first time that pMSC populations expressed these adhesion molecules including α7, α8, α10, αE, αM, β3, ICAM2, PECAM and selectin P ligand. Moreover, similar to other study [17] , we showed that pMSCs expressed these molecules α1, α2, α2b, α3, α4, α5, α6, α7, α8, α11, αV, β1, β4, β5, ICAM1, VCAM, CD166 and CD44. However, the significance of these molecules in pMSC biology should be further investigated, but it is likely that pMSCs express adhesion molecules to mediate their adhesion to endothelial cells and migration to tissues through a homing process similar to leukocytes.
pMSCs Express a Specific Combination of Chemokines/ Receptors
Chemotactic molecules such as chemokines are essential to attract MSCs to the damaged tissue [28] . Chemokines are a family of proteins that regulate many functions such as chemotaxis. The chemokine family is divided into four sub-families: CXC, CC, C and CX 3 C chemokines. Chemokine receptors are classified as G protein coupled receptors for CXC, CC, C or CX 3 C chemokines [29] . Our knowledge regarding the expression profile of chemokines/receptors by pMSCs is limited; thus we have performed this first comprehensive study to demonstrate that pMSCs express several Fig. 5 The effect of different cytokines on the proliferation of pMSCs (a) and the effect of different chemotactic factors (SDF, PDGF, HGF and MCP-1) on the migration of pMSCs (b). The proliferation of pMSCs was significantly suppressed in the presence of IL-4 (*P<0.01) and HGF (*P <0.01) whereas significantly increased in the presence of IL-1 (*P<0.01), IL-6 (*P<0.01), IL-8 (**P<0.05), RANTES (*P<0.01) and IL17A (*P <0.01). The chemotactic factors significantly (*P<0.0001) stimulated the migration of pMSCs in transwell migration plates. pMSCs isolated from Trypsin-treated tissues at passage one of 10 placentae were analyzed. Bars represent standard errors chemokine receptors including CCR1, CCR3, CCR4, CCR6, CCR7, CXCR1, CXCR3, CXCR4, CXCR5, CXCR6 and CX3CR1 as it has been previously reported [17, 20] . In addition, we report for the first time the expression of many chemokine ligands by pMSCs (Table 4) . However, some of these ligands and receptors were either absent or expressed at low level by pMSCs (Fig. 4) . This is may be because we used unstimulated cells in this study since the pre-treatment of MSCs with inflammatory cytokines such as TNF-α was shown to increase the expression of chemokine receptors [22] . In addition, the use of Western blot is a better technique than FACS since it can detect low level of protein [22] . The expression of chemokines by pMSCs may account for their migration ability as we showed in this study. However, more studies are essential to determine the precise functional roles for these molecules in mediating the pMSC repair response.
pMSCs Express a Specific Combination of Cytokines, Growth Factors and Immune Molecules Cytokines are signaling molecules that mediate many of cell functions, such as immune modulation and migration. BMMSCs express many cytokines [15, 30] , but our knowledge regarding the expression of cytokines by pMSCs is limited. Therefore, we performed this study to show that pMSCs express and secrete several inflammatory/anti-inflammatory cytokines (Table 5 ). However, the biological significance of these cytokines in pMSC function should be further examined. However, these cytokines may mediate pMSC migration as it has been reported for IL-1 and IL-6 [31, 32] . In addition, pMSCs may use these cytokines to mediate their immune functions through different mechanisms such as induction of regulatory T cells by IL-15 [33] , IL-10 and IL1Ra [34] or inhibition of T cell functions by IL-27 and IL-31 [35, 36] or antagonizing HIV infection by IL-32 [37] or reducing inflammation and killing cancerous cells by IL-24 [38, 39] . This is the first study which demonstrates that pMSCs isolated from chorionic villi by the explant method express a broad spectrum of cytokines, growth factor receptors (Tables 5 and 6 ) and costimulatory molecules (B7H3, CD273 and CD274) as well as the immune suppressive enzyme IDO, which can induce T cell death [40] [41] [42] [43] . These molecules can potentially mediate pMSC functions including proliferation, differentiation, angiogenesis, migration, program cell death (apoptosis), antitumor activity, antiviral function and immune modulatory functions. Therefore, our study demonstrates that our pMSC populations may have a significant potential in treating different types of human diseases including immune disorders, cancers and infectious diseases. However, we need to demonstrate the potential therapeutic ability of these pMSCs by performing functional studies in vitro and in vivo. Comprehensive analysis of pMSC properties may aid in deciding which clinical applications will benefit most from the use of pMSCs. For example, our data suggest pMSC populations are attractive candidates for the treatment of disorders involving T cells where immunosuppression of T cell activity by pMSCs may be advantageous. Multiple sclerosis, where autoreactive T cells mediate inflammation of the central nervous system (CNS), may benefit from the immunosuppressive molecules expressed by pMSCs.
Conclusion
We have devised a novel method using a tissue explant approach to isolate pMSCs from chorionic villous tissue of the normal human placenta. Our study is novel and comprehensive. We showed that pMSCs exhibited important features of the MSC lineage and expressed specific combinations of adhesion molecules, chemokines/receptors, cytokines/receptors and growth factors; many of which are known to be involved in cell proliferation, differentiation, migration and repair.
